|
|
||||||||
Commissariat à lEnergie Atomique (CEA)/Grenoble, Laboratoire de Biochimie et de Biophysique des Systèmes Intégrés (UMR 314 CEA/Centre National de la Recherche Scientifique), Grenoble, France
Promyelocytic human leukemia HL60 cells can be differentiated into neutrophil-like cells that exhibit an NADPH oxidase activity through direct stimulation of protein kinase C (PKC) with PMA or through formyl peptide receptor activation. We have isolated a variant HL60 clone that exhibited a conditional PMA-induced oxidative response depending on the agent used for the differentiation. While cells differentiated with DMSO responded to either PMA or N-formyl peptide (N-formyl-Met-Leu-Phe-Lys or fMLFK), cells differentiated with dibutyryl-cAMP (Bt2cAMP) responded to fMLFK but very poorly to PMA. However, in Bt2cAMP-differentiated cells, the expression of the different PKC isoforms was similar to that observed in DMSO-differentiated cells. Moreover, PMA was able to induce a normal phosphorylation of the cytosolic factor p47phox and to fully activate extracellular signal-regulated kinases (Erk1/2). Interestingly, Bt2cAMP-differentiated cells exhibited a strong and sustained O2- production when costimulated with PMA and suboptimal concentrations of fMLFK which were, per se, ineffective. This sustained response was only slightly reduced by the conjunction of the mitogen-activated protein (MAP) kinase kinase (MEK) inhibitor PD98059 and wortmannin, a phosphatidylinositol-3 kinase (PI3K) inhibitor. Variant HL60 cells that were stably transfected with a constitutively active form of Rac1 were able, when differentiated with Bt2cAMP, to secrete oxidant following PMA stimulation. Altogether, the results suggest that, in addition to the phosphorylation of p47phox, the activation of NADPH oxidase requires the activation of a Rac protein through a pathway that diverges at a point upstream of MEK and that is independent of the activation of wortmannin sensitive PI3K.
This article has been cited by other articles:
![]() |
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sanders, K. M. Sundar, L. He, B. Dinger, S. Fidone, and J. R. Hoidal Role of components of the phagocytic NADPH oxidase in oxygen sensing J Appl Physiol, October 1, 2002; 93(4): 1357 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Rabiet, M. Tardif, L. Braun, and F. Boulay Inhibitory effects of a dominant-interfering form of the Rho-GTPase Cdc42 in the chemoattractant-elicited signaling pathways leading to NADPH oxidase activation in differentiated HL-60 cells Blood, August 13, 2002; 100(5): 1835 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gorlach, R. P. Brandes, K. Nguyen, M. Amidi, F. Dehghani, and R. Busse A gp91phox Containing NADPH Oxidase Selectively Expressed in Endothelial Cells Is a Major Source of Oxygen Radical Generation in the Arterial Wall Circ. Res., July 7, 2000; 87(1): 26 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O'Kelly, A. Lewis, C. Peers, and P. J. Kemp O2 Sensing by Airway Chemoreceptor-derived Cells. PROTEIN KINASE C ACTIVATION REVEALS FUNCTIONAL EVIDENCE FOR INVOLVEMENT OF NADPH OXIDASE J. Biol. Chem., March 10, 2000; 275(11): 7684 - 7692. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Christophe, M.-J. Rabiet, M. Tardif, M.-D. Milcent, and F. Boulay Human Complement 5a (C5a) Anaphylatoxin Receptor (CD88) Phosphorylation Sites and Their Specific Role in Receptor Phosphorylation and Attenuation of G Protein-mediated Responses. DESENSITIZATION OF C5a RECEPTOR CONTROLS SUPEROXIDE PRODUCTION BUT NOT RECEPTOR SEQUESTRATION IN HL-60 CELLS J. Biol. Chem., January 21, 2000; 275(3): 1656 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Nessel, W. L. Henry Jr., B. Mastrofrancesco, J. S. Reichner, and J. E. Albina Vestigial respiratory burst activity in wound macrophages Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1587 - R1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2 J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |